These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 33143389)
1. Natural Compounds as Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors. Serrano-Marín J; Reyes-Resina I; Martínez-Pinilla E; Navarro G; Franco R Molecules; 2020 Oct; 25(21):. PubMed ID: 33143389 [TBL] [Abstract][Full Text] [Related]
2. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development. Müller CE; Schiedel AC; Baqi Y Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders. Lütjens R; Rocher JP Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635 [TBL] [Abstract][Full Text] [Related]
4. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors. Wootten D; Miller LJ Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292 [TBL] [Abstract][Full Text] [Related]
5. Natural allosteric modulators and their biological targets: molecular signatures and mechanisms. Bruder M; Polo G; Trivella DBB Nat Prod Rep; 2020 Apr; 37(4):488-514. PubMed ID: 32048675 [TBL] [Abstract][Full Text] [Related]
6. Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Burford NT; Watson J; Bertekap R; Alt A Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747 [TBL] [Abstract][Full Text] [Related]
7. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors. Feng Z; Hu G; Ma S; Xie XQ AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084 [TBL] [Abstract][Full Text] [Related]
8. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Conn PJ; Christopoulos A; Lindsley CW Nat Rev Drug Discov; 2009 Jan; 8(1):41-54. PubMed ID: 19116626 [TBL] [Abstract][Full Text] [Related]
9. Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery. Muratspahić E; Freissmuth M; Gruber CW Trends Pharmacol Sci; 2019 May; 40(5):309-326. PubMed ID: 30955896 [TBL] [Abstract][Full Text] [Related]
11. Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery. Wang Y; Yu Z; Xiao W; Lu S; Zhang J Drug Discov Today; 2021 Mar; 26(3):690-703. PubMed ID: 33301977 [TBL] [Abstract][Full Text] [Related]
12. The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor. Ortega JT; Jastrzebska B Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835521 [TBL] [Abstract][Full Text] [Related]
14. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? Sriram K; Insel PA Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813 [TBL] [Abstract][Full Text] [Related]
16. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain. Felder CC Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249 [TBL] [Abstract][Full Text] [Related]
17. Synoptic pharmacology: Detecting and assessing the pharmacological significance of ligands for orphan receptors. Kenakin TP Pharmacol Res; 2016 Dec; 114():284-290. PubMed ID: 26804250 [TBL] [Abstract][Full Text] [Related]
18. Druggable Lipid GPCRs: Past, Present, and Prospects. Mizuno H; Kihara Y Adv Exp Med Biol; 2020; 1274():223-258. PubMed ID: 32894513 [TBL] [Abstract][Full Text] [Related]
19. Allosteric Modulators of the Class A G Protein Coupled Receptors. Tschammer N Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557 [TBL] [Abstract][Full Text] [Related]
20. The Quantitative Characterization of Functional Allosteric Effects. Kenakin T Curr Protoc Pharmacol; 2017 Mar; 76():9.22.1-9.22.10. PubMed ID: 28306151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]